SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

MHRA Approves Gene-Editing Treatment for Children With Blood Disorders

The UK regulator approved the gene-editing treatment for children aged five and over with serious inherited blood disorders.

Related stories